Has Hiroo Takayama, MD received payments from drug or device companies?

Yes. Drug and device makers reported $42,287 in general payments to Hiroo Takayama, MD across 210 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Hiroo Takayama, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Hiroo Takayama, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Hiroo Takayama, MD

Thoracic Surgery (Cardiothoracic Vascular Surgery) · New York, NYNPI 1063522001

Payments from drug & device makers

What this record shows

The money is spread across several categories — travel and lodging (39.0%), food and beverage and speaking fees — rather than concentrated in one kind of arrangement. 14 manufacturers reported payments, led by Edwards Lifesciences at 40.4% of the total. Reporting peaked in 2019 at $18,353 and has fallen 64.8% since, to $6,462 in 2025.

$42,287in general payments, 2019–2025

Across 210 payments — averaging $201.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Edwards Lifesciences$17K
Artivion, Inc.$16K
Bolton Medical Inc$5K
Abbott$2K
Clearflow Inc.$1K
Cook Medical LLC$391
plus $1K from 8 others

$631,177in research payments, 2019–2025

Across 149 payments — averaging $4236.09 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Edwards Lifesciences$464K
Artivion, Inc.$118K
Atricure, Inc.$33K
Bolton Medical Inc$13K
Livanova USA, Inc.$3K

What the payments were for

Consulting fees$2,7897%
Speaking & faculty fees$7,64718%
Travel & lodging$16,50339%
Food & beverage$11,34827%
Education$4,0009%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Edwards Lifesciences	67	$17,076
Artivion, Inc.	87	$15,907
Bolton Medical Inc	13	$4,601
Abbott	23	$1,998
Clearflow Inc.	2	$1,051
Cook Medical LLC	3	$391
Atricure, Inc.	3	$389
Abiomed	3	$355
Medtronic	2	$245
Medistim USA, Inc.	1	$100
Integra Lifesciences Corporation	2	$79
Convatec Inc.	2	$41
Guard Medical Inc.	1	$30
Baxter Healthcare	1	$25

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

EDWARDS INTUITY Elite valve system$7,796
AMDS-Ascyrus Medical$5,451
Grafts$4,000
BioGlue$3,752
On-X$3,752
PhotoFix$3,752
CRYOVALVE SG PULMONARY HUMAN HEART VALVE$2,709
INSPIRIS RESILIA aortic valve$1,284
Jotec Products$1,175
PleuraFlow$1,051
MITRIS RESILIA Mitral Valve$755
Cardiac non-SynerGraft$707
THORATEC HEARTMATE 3 LVAS IMPLANT KIT$680
ON-X AORTIC HEART VALVE WITH CONFORM-X SEWING RING AND EXTENDED HOLDER$460
ATRICURE ATRICLIP LAA EXCLUSION$389
HeartMate 3 Left Ventricular Assist Device$352
Impella$286
Cook$266
Relay Plus$248
ATRICURE CRYOSURGICAL SYSTEM$247

How this compares

$42,287 in reported general payments places this provider in the 85th percentile of 383 thoracic surgery (cardiothoracic vascular surgery) providers in New York.

See all thoracic surgery (cardiothoracic vascular surgery) providers in New York →

Medicare billing

Part B allowed, 2024

$414,589

Medicare patients

283

Services billed

601

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Atorvastatin Calcium	14	$110
Mupirocin	14	$90
Amiodarone Hcl	13	$70

Paid to pharmacies, not to this prescriber.

Other thoracic surgery (cardiothoracic vascular surgery) in New York

Aubrey GallowayNew York$5.7M
Gilbert TangNew York$842K
Michael ZervosNew York$811K
Elias ZiasNew York$465K
Isaac GeorgeNew York$395K
Eugene GrossiNew York$350K
Costas BizekisNew York$321K
Brendon StilesNew York$314K
Daniela MolenaNew York$221K
Arnar GeirssonNew York$218K

See the full list for New York →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →